Your session is about to expire
← Back to Search
Immersive Virtual Reality for Chronic Back Pain
N/A
Waitlist Available
Led By Nancy Baker, ScD
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
20 to 75 years old
Any Back Pain (including neck pain) that has lasted greater than 3 months due to non-cancer related injury or illness.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up median pre and post intervention sensitivity to pressure scores in kilograms
Awards & highlights
Study Summary
This trial will assess whether Immersive Virtual Reality (IVR) can help with symptoms of Chronic Back Pain (CBP), as well as affect and tolerance to stimuli. 20 adults with CBP will participate in two IVR sessions, one 10-minute and one 20-minute. Results will be measured using self-report questionnaires and sensory testing.
Eligible Conditions
- Chronic Back Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are between the ages of 20 and 75.
Select...
You have had ongoing back pain (including neck pain) for more than 3 months, not caused by cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in pain intensity from before to immediately after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pain intensity from before to immediately after intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mechanical Pressure Pain Thresholds (MPPTh)
Mechanical Temporal Summation of Pain (MTSP)
Pain Numerical Rating Scale
Secondary outcome measures
PANAS
PROMIS Fatigue
Other outcome measures
User Engagement Scale
Trial Design
2Treatment groups
Experimental Treatment
Group I: 20 Minutes/10 MinutesExperimental Treatment1 Intervention
Subject takes part in 20 minute VR experience first and 10 minute VR experience second
Group II: 10 Minutes/20 MinutesExperimental Treatment1 Intervention
Subject takes part in 10 minute VR experience first and 20 minute VR experience second
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immersive Virtual Reality
2021
N/A
~110
Find a Location
Who is running the clinical trial?
Tufts Clinical and Translational Science InstituteUNKNOWN
1 Previous Clinical Trials
23 Total Patients Enrolled
Tufts UniversityLead Sponsor
260 Previous Clinical Trials
661,099 Total Patients Enrolled
Nancy Baker, ScDPrincipal Investigator - Tufts University
Tufts University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger